Literature DB >> 28063737

Discovery of Centrosomal Protein 70 as an Important Player in the Development and Progression of Breast Cancer.

Xingjuan Shi1, Dengwen Li2, Yujue Wang3, Shiyu Liu2, Juan Qin2, Jun Wang2, Jie Ran4, Yu Zhang3, Qinghai Huang3, Xiangdong Liu3, Jun Zhou5, Min Liu6.   

Abstract

Centrosome abnormalities have been implicated in the development and progression of breast cancer. However, the molecular players involved in the above processes remain largely uncharacterized. Herein, we identify centrosomal protein 70 (Cep70) as an important factor that mediates breast cancer growth and metastasis. Cep70 is up-regulated in breast cancer tissues and cell lines, and its expression is closely correlated with several clinicopathologic variables associated with breast cancer progression. Mechanistic studies reveal that the up-regulation of Cep70 in breast cancer occurs at the mRNA level and is independent of gene amplification. Cep70 promotes breast cancer cell proliferation and colony formation in vitro and increases tumor growth in mice. In addition, Cep70 stimulates breast cancer cell migration and invasion in vitro. Bioluminescence imaging analysis further shows that Cep70 enhances breast cancer lung metastasis in mice. Together, these results demonstrate a critical role for Cep70 in the development and progression of breast cancer and have important implications in the diagnosis and therapy of this malignancy.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28063737     DOI: 10.1016/j.ajpath.2016.11.005

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  6 in total

1.  A role for Cep70 in centriole amplification in multiciliated cells.

Authors:  Sun K Kim; Eva Brotslaw; Virginie Thome; Jen Mitchell; Rosa Ventrella; Caitlin Collins; Brian Mitchell
Journal:  Dev Biol       Date:  2020-12-04       Impact factor: 3.582

2.  Centrosomal Protein 70 Is a Mediator of Paclitaxel Sensitivity.

Authors:  Xingjuan Shi; Yujue Wang; Xiaoou Sun; Chan Wang; Peng Jiang; Yu Zhang; Qinghai Huang; Xiangdong Liu; Dengwen Li; Jun Zhou; Min Liu
Journal:  Int J Mol Sci       Date:  2017-06-20       Impact factor: 5.923

3.  Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.

Authors:  Sherona R Sirkisoon; Richard L Carpenter; Tadas Rimkus; Ashley Anderson; Alexandria Harrison; Allison M Lange; Guangxu Jin; Kounosuke Watabe; Hui-Wen Lo
Journal:  Oncogene       Date:  2018-02-16       Impact factor: 9.867

Review 4.  Targeted inhibition of histone deacetylase 6 in inflammatory diseases.

Authors:  Jie Ran; Jun Zhou
Journal:  Thorac Cancer       Date:  2019-01-21       Impact factor: 3.500

5.  STVNa Attenuates Isoproterenol-Induced Cardiac Hypertrophy Response through the HDAC4 and Prdx2/ROS/Trx1 Pathways.

Authors:  Fei Liu; Hao Su; Bo Liu; Ying Mei; Qingjin Ke; Xiaoou Sun; Wen Tan
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

6.  ndufa7 plays a critical role in cardiac hypertrophy.

Authors:  Xingjuan Shi; Yu Zhang; Ru Chen; Yijie Gong; Mingming Zhang; Rui Guan; Ori D Rotstein; Xiangdong Liu; Xiao-Yan Wen
Journal:  J Cell Mol Med       Date:  2020-09-29       Impact factor: 5.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.